Latest filing published 11 Feb 2026 for Wave Life Sciences Ltd.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Kyle Moran in Wave Life Sciences Ltd., where the filings describe the role as finance chief. Over a trading history stretching from 16 February 2022 to 5 February 2026, the count stands at 10 filings.
Every open-market trade on record is a sale: 5 sales worth €445k. Other entries cover 3 share grants and 2 option exercises.
The record was last updated on 11 February 2026 with a share grant in Wave Life Sciences Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations